A citation-based method for searching scientific literature

Josep Tabernero, Paulo M Hoff, Lin Shen, Atsushi Ohtsu, Manish A Shah, Karen Cheng, Chunyan Song, Haiyan Wu, Jennifer Eng-Wong, Katherine Kim, Yoon-Koo Kang. Lancet Oncol 2018
Times Cited: 195

List of shared articles

Times cited

HER2 in gastric adenocarcinoma: where do we stand today?
Khalil El Gharib, Makram Khoury, Hampig Raphael Kourie. Per Med 2022

Current status and future perspectives in HER2 positive advanced gastric cancer.
G Roviello, M Catalano, L F Iannone, L Marano, M Brugia, G Rossi, G Aprile, L Antonuzzo. Clin Transl Oncol 2022

Interest of the Addition of Taxanes to Standard Treatment in First-Line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients.
Emeline Orillard, Julie Henriques, Dewi Vernerey, Hamadi Almotlak, Fabien Calcagno, Francine Fein, Serge Fratté, Marine Jary, Elodie Klajer, Angelique Vienot,[...]. Front Oncol 2022

Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers.
Jeremy Chuang, Samuel Klempner, Kevin Waters, Katelyn Atkins, Joseph Chao, May Cho, Andrew Hendifar, Alexandra Gangi, Miguel Burch, Pareen Mehta,[...]. Diseases 2022

Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?
Giandomenico Roviello, Giuseppe Aprile, Alberto D'Angelo, Luigi Francesco Iannone, Franco Roviello, Karol Polom, Enrico Mini, Martina Catalano. Gastric Cancer 2021

Trastuzumab deruxtecan for the treatment of HER2-positive gastric cancer.
Saori Mishima, Kohei Shitara. Expert Opin Biol Ther 2021

HER2-targeted therapies in gastric cancer.
Yinxing Zhu, Xuedan Zhu, Xiaowei Wei, Cuiju Tang, Wenwen Zhang. Biochim Biophys Acta Rev Cancer 2021

Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them.
Angelica Petrillo, Emilio Francesco Giunta, Annalisa Pappalardo, Davide Bosso, Laura Attademo, Cinzia Cardalesi, Anna Diana, Antonietta Fabbrocini, Teresa Fabozzi, Pasqualina Giordano,[...]. J Clin Med 2021

Hopes and failures in front-line advanced HER2-positive gastric cancer therapy.
Fanming Kong, Yang Yao, Renfen Deng, Xiaojiang Li, Yingjie Jia. Anticancer Drugs 2021

Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma.
Daniel V Catenacci, Joseph Chao, Kei Muro, Salah Eddin Al-Batran, Samuel J Klempner, Zev A Wainberg, Manish A Shah, Sun Young Rha, Atsushi Ohtsu, Astra M Liepa,[...]. Oncologist 2021